Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of “Buy” by Analysts
Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received an average rating of “Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price objective among […]
Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received an average rating of “Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price objective among […]
